Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL CARE SERVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL NUCLEIC ACID BASED DRUGS SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL CARE SERVICES MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES MODEL
5 INDUSTRY INSIGHTS
5.1 PATENT ANALYSIS
5.1.1 PATENT LANDSCAPE
5.1.2 USPTO NUMBER
5.1.3 PATENT EXPIRY
5.1.4 EPIO NUMBER
5.1.5 PATENT STRENGTH AND QUALITY
5.1.6 PATENT CLAIMS
5.1.7 PATENT CITATIONS
5.1.8 PATENT LITIGATION AND LICENSING
5.1.9 FILE OF PATENT
5.1.10 PATENT RECEIVED CONTRIES
5.1.11 TECHNOLOGY BACKGROUND
5.2 DRUG TREATMENT RATE BY MATURED MARKETS
5.3 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES
5.4 PATIENT FLOW DIAGRAM
5.5 KEY PRICING STRATEGIES
5.6 KEY PATIENT ENROLLMENT STRATEGIES
5.7 INTERVIEWS WITH SPECIALIST
5.8 OTHER KOL SNAPSHOTS
6 MERGERS AND ACQUISITION
6.1 LICENSING
6.2 COMMERCIALIZATION AGREEMENTS
7 REGULATORY FRAMEWORK
7.1 REGULATORY APPROVAL PROCESS
7.2 GEOGRAPHIES’ EASE OF REGULATORY APPROVAL
7.3 REGULATORY APPROVAL PATHWAYS
7.4 LICENSING AND REGISTRATION
7.5 POST-MARKETING SURVEILLANCE
8 MARKET OVERVIEW
8.1 DRIVERS
8.2 RESTRAINTS
8.3 OPPORTUNITIES
8.4 CHALLENGES
9 GLOBAL CARE SERVICES MARKET, BY COMPONENT
9.1 OVERVIEW
9.2 SOFTWARE
9.2.1 BY TYPE
9.2.1.1. CARE MANAGEMENT PLATFORMS
9.2.1.2. PATIENT ENGAGEMENT SOLUTIONS
9.2.1.3. ANALYTICS AND REPORTING TOOLS
9.2.1.4. WORKFLOW AUTOMATION TOOLS
9.2.1.5. OTHERS
9.2.2 BY MODE
9.2.2.1. INTEGRATED
9.2.2.2. STANDALONE
9.2.3 BY OPERATING SYSTEM
9.2.3.1. ANDROID
9.2.3.2. WINDOWS
9.2.3.3. IOS
9.2.3.4. OTHERS
9.3 SERVICES
9.3.1 CONSULTING AND TRAINING
9.3.2 IMPLEMENTATION SERVICES
9.3.3 SUPPORT AND MAINTENANCE
9.3.4 MANAGED SERVICES
9.3.5 OTHERS
10 GLOBAL CARE SERVICES MARKET, BY DELIVERY MODE
10.1 OVERVIEW
10.2 ON-PREMISE
10.3 CLOUD-BASED
10.3.1 PUBLIC CLOUD
10.3.2 PRIVATE CLOUD
10.3.3 HYBRID CLOUD
10.4 OTHERS
11 GLOBAL CARE SERVICES MARKET , BY APPLICATION
11.1 OVERVIEW
11.2 DISEASE MANAGEMENT
11.2.1 CHRONIC DISEASE MANAGEMENT
11.2.1.1. DIABETES MANAGEMENT PROGRAMS
11.2.1.1.1. INSULIN THERAPY OPTIMIZATION
11.2.1.1.2. CONTINUOUS GLUCOSE MONITORING (CGM) TRAINING
11.2.1.1.3. DIABETIC DIET AND NUTRITION COUNSELING
11.2.1.1.4. OTHERS
11.2.1.2. HYPERTENSION CONTROL INITIATIVES
11.2.1.2.1. MEDICATION ADHERENCE SUPPORT
11.2.1.2.2. BLOOD PRESSURE MONITORING WORKSHOPS
11.2.1.2.3. SALT-INTAKE REDUCTION EDUCATION
11.2.1.2.4. OTHERS
11.2.1.3. COPD AND ASTHMA CARE PLANS
11.2.1.3.1. INHALER USAGE TRAINING
11.2.1.3.2. PULMONARY REHABILITATION PROGRAMS
11.2.1.3.3. EMERGENCY ACTION PLANS FOR EXACERBATIONS
11.2.1.4. OTHERS
11.2.2 PREVENTIVE CARE
11.2.2.1. VACCINATION CAMPAIGNS
11.2.2.1.1. FLU VACCINATION DRIVES
11.2.2.1.2. SCHOOL-BASED IMMUNIZATION PROGRAMS
11.2.2.1.3. ADULT VACCINATION AWARENESS CAMPAIGNS
11.2.2.1.4. OTHERS
11.2.2.2. HEALTH SCREENINGS AND ASSESSMENTS
11.2.2.2.1. ANNUAL PHYSICAL EXAMS
11.2.2.2.2. CANCER SCREENING INITIATIVES
11.2.2.2.3. CARDIOVASCULAR RISK ASSESSMENTS
11.2.2.2.4. OTHERS
11.2.2.3. LIFESTYLE MODIFICATION PROGRAMS
11.2.2.3.1. SMOKING CESSATION PROGRAMS
11.2.2.3.2. WEIGHT MANAGEMENT CLINICS
11.2.2.3.3. STRESS MANAGEMENT TECHNIQUES
11.2.2.3.4. OTHERS
11.2.2.4. OTHERS
11.2.3 POST-ACUTE CARE MANAGEMENT
11.2.3.1. REHABILITATION SERVICES
11.2.3.1.1. PHYSICAL THERAPY SESSIONS
11.2.3.1.2. SPEECH AND LANGUAGE THERAPY
11.2.3.1.3. OCCUPATIONAL THERAPY FOR DAILY LIVING
11.2.3.1.4. OTHERS
11.2.3.2. HOME-BASED RECOVERY PROGRAMS
11.2.3.2.1. POST-SURGICAL CARE AT HOME
11.2.3.2.2. NUTRITIONAL SUPPORT SERVICES
11.2.3.2.3. REMOTE PHYSIOTHERAPY ASSISTANCE
11.2.3.2.4. OTHERS
11.2.3.3. TRANSITIONAL CARE COORDINATION
11.2.3.3.1. DISCHARGE PLANNING SERVICES
11.2.3.3.2. FOLLOW-UP APPOINTMENT SCHEDULING
11.2.3.3.3. MEDICATION RECONCILIATION AND EDUCATION
11.2.3.3.4. OTHERS
11.2.3.4. OTHERS
11.3 CASE MANAGEMENT
11.3.1 INDIVIDUAL CASE MANAGEMENT
11.3.1.1. PERSONALIZED CARE PLANS
11.3.1.1.1. TAILORED TREATMENT PROTOCOLS
11.3.1.1.2. HOLISTIC WELLNESS APPROACHES
11.3.1.1.3. BEHAVIORAL HEALTH INTEGRATION
11.3.1.1.4. OTHERS
11.3.1.2. ONE-ON-ONE COUNSELING SERVICES
11.3.1.2.1. PSYCHOLOGICAL SUPPORT FOR CHRONIC ILLNESS
11.3.1.2.2. FINANCIAL AND INSURANCE GUIDANCE
11.3.1.2.3. CAREGIVER EDUCATION SESSIONS
11.3.1.2.4. OTHERS
11.3.1.3. FINANCIAL ASSISTANCE COORDINATION
11.3.1.3.1. CHARITY AND GRANT APPLICATION ASSISTANCE
11.3.1.3.2. PAYMENT PLAN NEGOTIATIONS
11.3.1.3.3. EXPENSE TRACKING AND BUDGETING TOOLS
11.3.1.3.4. OTHERS
11.3.1.4. OTHERS
11.3.2 GROUP CASE MANAGEMENT
11.3.2.1. SUPPORT GROUP COORDINATION
11.3.2.1.1. PEER-TO-PEER COUNSELING PROGRAMS
11.3.2.1.2. SHARED DECISION-MAKING WORKSHOPS
11.3.2.1.3. CHRONIC ILLNESS RESOURCE HUBS
11.3.2.1.4. OTHERS
11.3.2.2. DISEASE-SPECIFIC COMMUNITY PROGRAMS
11.3.2.2.1. CANCER SURVIVOR NETWORKS
11.3.2.2.2. DIABETES PREVENTION ALLIANCES
11.3.2.2.3. CARDIAC REHAB SUPPORT GROUPS
11.3.2.2.4. OTHERS
11.3.2.3. RESOURCE SHARING PLATFORMS
11.3.2.3.1. DIGITAL HEALTH LIBRARIES
11.3.2.3.2. COMMUNITY CARE APPS
11.3.2.3.3. VIRTUAL COLLABORATION PORTALS
11.3.2.3.4. OTHERS
11.3.2.4. OTHERS
11.4 UTILIZATION MANAGEMENT
11.4.1 MEDICAL NECESSITY REVIEW
11.4.1.1. PRE-AUTHORIZATION PROCEDURES
11.4.1.1.1. SPECIALIST REFERRAL VERIFICATION
11.4.1.1.2. TREATMENT PLAN APPROVALS
11.4.1.1.3. COVERAGE ELIGIBILITY ASSESSMENTS
11.4.1.1.4. OTHERS
11.4.1.2. CONCURRENT REVIEW PROCESSES
11.4.1.2.1. INPATIENT STAY EVALUATIONS
11.4.1.2.2. LENGTH OF STAY OPTIMIZATION
11.4.1.2.3. THERAPY PROGRESS MONITORING
11.4.1.2.4. OTHERS
11.4.1.3. RETROSPECTIVE REVIEW MECHANISMS
11.4.1.3.1. CLAIMS ANALYSIS FOR PAST TREATMENTS
11.4.1.3.2. AUDIT AND FRAUD DETECTION
11.4.1.3.3. OUTCOME-BASED REIMBURSEMENT MODELS
11.4.1.3.4. OTHERS
11.4.1.4. OTHERS
11.4.2 COST CONTAINMENT ANALYSIS
11.4.2.1. COMPARATIVE COST ANALYTICS
11.4.2.1.1. BENCHMARKING AGAINST INDUSTRY STANDARDS
11.4.2.1.2. PRICING TRANSPARENCY TOOLS
11.4.2.1.3. DATA-DRIVEN CONTRACT NEGOTIATIONS
11.4.2.1.4. OTHERS
11.4.2.2. ALTERNATIVE TREATMENT EVALUATIONS
11.4.2.2.1. GENERIC VS. BRAND MEDICATION STUDIES
11.4.2.2.2. HOME-BASED VS. FACILITY-BASED CARE ANALYSES
11.4.2.2.3. EMERGING THERAPY COST ASSESSMENTS
11.4.2.2.4. OTHERS
11.4.2.3. NETWORK OPTIMIZATION STRATEGIES
11.4.2.3.1. PROVIDER NETWORK TIERING
11.4.2.3.2. CONTRACT RENEGOTIATION STRATEGIES
11.4.2.3.3. REGIONAL CARE COORDINATION MODELS
11.4.2.3.4. OTHERS
11.4.2.4. OTHERS
11.5 OTHERS
12 GLOBAL CARE SERVICES MARKET , BY PURCHASE MODE
12.1 OVERVIEW
12.1.1 GROUP PURCHASE ORGANIZATION
12.1.2 INDIVIDUAL PURCHASE
13 GLOBAL CARE SERVICES MARKET , BY END USER
13.1 OVERVIEW
13.2 PAYERS
13.3 PROVIDERS
13.3.1 HOSPITAL
13.3.2 SPECIALITY CLINICS
13.3.3 OTHERS
13.4 OTHERS
14 GLOBAL CARE SERVICES MARKET , SWOT AND DBMR ANALYSIS
15 GLOBAL CARE SERVICES MARKET , COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: GLOBAL
15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
15.3 COMPANY SHARE ANALYSIS: EUROPE
15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
15.5 MERGERS & ACQUISITIONS
15.6 NEW PRODUCT DEVELOPMENT & APPROVALS
15.7 EXPANSIONS
15.8 REGULATORY CHANGES
15.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
16 GLOBAL CARE SERVICES MARKET , BY REGION
GLOBAL CARE SERVICES MARKET , (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
16.1 NORTH AMERICA
16.1.1 U.S.
16.1.2 CANADA
16.1.3 MEXICO
16.2 EUROPE
16.2.1 GERMANY
16.2.2 U.K.
16.2.3 ITALY
16.2.4 FRANCE
16.2.5 SPAIN
16.2.6 RUSSIA
16.2.7 SWITZERLAND
16.2.8 TURKEY
16.2.9 BELGIUM
16.2.10 NETHERLANDS
16.2.11 DENMARK
16.2.12 SWEDEN
16.2.13 POLAND
16.2.14 NORWAY
16.2.15 FINLAND
16.2.16 REST OF EUROPE
16.3 ASIA-PACIFIC
16.3.1 JAPAN
16.3.2 CHINA
16.3.3 SOUTH KOREA
16.3.4 INDIA
16.3.5 SINGAPORE
16.3.6 THAILAND
16.3.7 INDONESIA
16.3.8 MALAYSIA
16.3.9 PHILIPPINES
16.3.10 AUSTRALIA
16.3.11 NEW ZEALAND
16.3.12 VIETNAM
16.3.13 TAIWAN
16.3.14 REST OF ASIA-PACIFIC
16.4 SOUTH AMERICA
16.4.1 BRAZIL
16.4.2 ARGENTINA
16.4.3 REST OF SOUTH AMERICA
16.5 MIDDLE EAST AND AFRICA
16.5.1 SOUTH AFRICA
16.5.2 EGYPT
16.5.3 BAHRAIN
16.5.4 UNITED ARAB EMIRATES
16.5.5 KUWAIT
16.5.6 OMAN
16.5.7 QATAR
16.5.8 SAUDI ARABIA
16.5.9 REST OF MEA
16.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
17 GLOBAL CARE SERVICES MARKET , COMPANY PROFILE
17.1 EXLSERVICE HOLDINGS, INC.
17.1.1 COMPANY OVERVIEW
17.1.2 REVENUE ANALYSIS
17.1.3 GEOGRAPHIC PRESENCE
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENTS
17.2 ZYTER
17.2.1 COMPANY OVERVIEW
17.2.2 REVENUE ANALYSIS
17.2.3 GEOGRAPHIC PRESENCE
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 MEDECISION
17.3.1 COMPANY OVERVIEW
17.3.2 REVENUE ANALYSIS
17.3.3 GEOGRAPHIC PRESENCE
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENTS
17.4 ZEOMEGA
17.4.1 COMPANY OVERVIEW
17.4.2 REVENUE ANALYSIS
17.4.3 GEOGRAPHIC PRESENCE
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENTS
17.5 COGNIZANT
17.5.1 COMPANY OVERVIEW
17.5.2 REVENUE ANALYSIS
17.5.3 GEOGRAPHIC PRESENCE
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENTS
17.6 ORACLE
17.6.1 COMPANY OVERVIEW
17.6.2 REVENUE ANALYSIS
17.6.3 GEOGRAPHIC PRESENCE
17.6.4 PRODUCT PORTFOLIO
17.6.5 RECENT DEVELOPMENTS
17.7 DXC TECHNOLOGY
17.7.1 COMPANY OVERVIEW
17.7.2 REVENUE ANALYSIS
17.7.3 GEOGRAPHIC PRESENCE
17.7.4 PRODUCT PORTFOLIO
17.7.5 RECENT DEVELOPMENTS
17.8 CERNER CORPORATION
17.8.1 COMPANY OVERVIEW
17.8.2 REVENUE ANALYSIS
17.8.3 GEOGRAPHIC PRESENCE
17.8.4 PRODUCT PORTFOLIO
17.8.5 RECENT DEVELOPMENTS
17.9 MEDTRONIC
17.9.1 COMPANY OVERVIEW
17.9.2 REVENUE ANALYSIS
17.9.3 GEOGRAPHIC PRESENCE
17.9.4 PRODUCT PORTFOLIO
17.9.5 RECENT DEVELOPMENTS
17.1 SIEMENS HEALTHINEERS
17.10.1 COMPANY OVERVIEW
17.10.2 REVENUE ANALYSIS
17.10.3 GEOGRAPHIC PRESENCE
17.10.4 PRODUCT PORTFOLIO
17.10.5 RECENT DEVELOPMENTS
17.11 GE HEALTHCARE
17.11.1 COMPANY OVERVIEW
17.11.2 REVENUE ANALYSIS
17.11.3 GEOGRAPHIC PRESENCE
17.11.4 PRODUCT PORTFOLIO
17.11.5 RECENT DEVELOPMENTS
17.12 VERINT SYSTEMS
17.12.1 COMPANY OVERVIEW
17.12.2 REVENUE ANALYSIS
17.12.3 GEOGRAPHIC PRESENCE
17.12.4 PRODUCT PORTFOLIO
17.12.5 RECENT DEVELOPMENTS
17.13 CHANGE HEALTHCARE
17.13.1 COMPANY OVERVIEW
17.13.2 REVENUE ANALYSIS
17.13.3 GEOGRAPHIC PRESENCE
17.13.4 PRODUCT PORTFOLIO
17.13.5 RECENT DEVELOPMENTS
17.14 INTELLISOFT GROUP
17.14.1 COMPANY OVERVIEW
17.14.2 REVENUE ANALYSIS
17.14.3 GEOGRAPHIC PRESENCE
17.14.4 PRODUCT PORTFOLIO
17.14.5 RECENT DEVELOPMENTS
17.15 OPTUM
17.15.1 COMPANY OVERVIEW
17.15.2 REVENUE ANALYSIS
17.15.3 GEOGRAPHIC PRESENCE
17.15.4 PRODUCT PORTFOLIO
17.15.5 RECENT DEVELOPMENTS
17.16 NEXTGEN HEALTHCARE
17.16.1 COMPANY OVERVIEW
17.16.2 REVENUE ANALYSIS
17.16.3 GEOGRAPHIC PRESENCE
17.16.4 PRODUCT PORTFOLIO
17.16.5 RECENT DEVELOPMENTS
17.17 LUMEN TECHNOLOGIES
17.17.1 COMPANY OVERVIEW
17.17.2 REVENUE ANALYSIS
17.17.3 GEOGRAPHIC PRESENCE
17.17.4 PRODUCT PORTFOLIO
17.17.5 RECENT DEVELOPMENTS
17.18 INFOR HEALTHCARE
17.18.1 COMPANY OVERVIEW
17.18.2 REVENUE ANALYSIS
17.18.3 GEOGRAPHIC PRESENCE
17.18.4 PRODUCT PORTFOLIO
17.18.5 RECENT DEVELOPMENTS
17.19 ATOS
17.19.1 COMPANY OVERVIEW
17.19.2 REVENUE ANALYSIS
17.19.3 GEOGRAPHIC PRESENCE
17.19.4 PRODUCT PORTFOLIO
17.19.5 RECENT DEVELOPMENTS
17.2 MEDISOLV
17.20.1 COMPANY OVERVIEW
17.20.2 REVENUE ANALYSIS
17.20.3 GEOGRAPHIC PRESENCE
17.20.4 PRODUCT PORTFOLIO
17.20.5 RECENT DEVELOPMENTS
17.21 CIGNA HEALTH SERVICES
17.21.1 COMPANY OVERVIEW
17.21.2 REVENUE ANALYSIS
17.21.3 GEOGRAPHIC PRESENCE
17.21.4 PRODUCT PORTFOLIO
17.21.5 RECENT DEVELOPMENTS
17.22 WIPRO
17.22.1 COMPANY OVERVIEW
17.22.2 REVENUE ANALYSIS
17.22.3 GEOGRAPHIC PRESENCE
17.22.4 PRODUCT PORTFOLIO
17.22.5 RECENT DEVELOPMENTS
17.23 ACCUHEALTH
17.23.1 COMPANY OVERVIEW
17.23.2 REVENUE ANALYSIS
17.23.3 GEOGRAPHIC PRESENCE
17.23.4 PRODUCT PORTFOLIO
17.23.5 RECENT DEVELOPMENTS
17.24 PHILIPS HEALTHCARE
17.24.1 COMPANY OVERVIEW
17.24.2 REVENUE ANALYSIS
17.24.3 GEOGRAPHIC PRESENCE
17.24.4 PRODUCT PORTFOLIO
17.24.5 RECENT DEVELOPMENTS
17.25 IBM
17.25.1 COMPANY OVERVIEW
17.25.2 REVENUE ANALYSIS
17.25.3 GEOGRAPHIC PRESENCE
17.25.4 PRODUCT PORTFOLIO
17.25.5 RECENT DEVELOPMENTS
17.26 TATA CONSULTANCY SERVICES
17.26.1 COMPANY OVERVIEW
17.26.2 REVENUE ANALYSIS
17.26.3 GEOGRAPHIC PRESENCE
17.26.4 PRODUCT PORTFOLIO
17.26.5 RECENT DEVELOPMENTS
17.27 MCKESSON CORPORATION
17.27.1 COMPANY OVERVIEW
17.27.2 REVENUE ANALYSIS
17.27.3 GEOGRAPHIC PRESENCE
17.27.4 PRODUCT PORTFOLIO
17.27.5 RECENT DEVELOPMENTS
17.28 HEALTH CATALYST
17.28.1 COMPANY OVERVIEW
17.28.2 REVENUE ANALYSIS
17.28.3 GEOGRAPHIC PRESENCE
17.28.4 PRODUCT PORTFOLIO
17.28.5 RECENT DEVELOPMENTS
17.29 PEGASYSTEMS INC
17.29.1 COMPANY OVERVIEW
17.29.2 REVENUE ANALYSIS
17.29.3 GEOGRAPHIC PRESENCE
17.29.4 PRODUCT PORTFOLIO
17.29.5 RECENT DEVELOPMENTS
17.3 A&D COMPANY LIMITED
18 RELATED REPORTS
19 CONCLUSION
20 QUESTIONNAIRE
21 ABOUT DATA BRIDGE MARKET RESEARCH
